Free Trial

Boston Scientific (BSX: Baa1/BBB+) vs Medtronic (MDT: A3/A)

HEALTHCARE
  • Medtronic enjoys the tightest spreads in the MedTech sector on account of its single-A rating. It currently trades around -15bps inside Boston Scientific.
  • MDT's rating has been is a former AA- name which is now single A, whereas BSX has been as low as Ba2/BB+ and is on an upward path - currently BBB+.
  • In the past 5years, BSX equity has rallied 81% vs MDT -21% (MDT does pay a dividend of 3.5% but not enough to account for the relative return).
  • BSX revenue has increased +41%; NetDebt fallen -24%
  • MDT revenue has decreased -7%; NetDebt increased +16%
  • Current NetDebt to Ebitda for BSX is 1.6x ; MDT 1.9x

Source: MNI, Bloomberg


121 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • Medtronic enjoys the tightest spreads in the MedTech sector on account of its single-A rating. It currently trades around -15bps inside Boston Scientific.
  • MDT's rating has been is a former AA- name which is now single A, whereas BSX has been as low as Ba2/BB+ and is on an upward path - currently BBB+.
  • In the past 5years, BSX equity has rallied 81% vs MDT -21% (MDT does pay a dividend of 3.5% but not enough to account for the relative return).
  • BSX revenue has increased +41%; NetDebt fallen -24%
  • MDT revenue has decreased -7%; NetDebt increased +16%
  • Current NetDebt to Ebitda for BSX is 1.6x ; MDT 1.9x

Source: MNI, Bloomberg